Page last updated: 2024-09-05

sorafenib and oleic acid

sorafenib has been researched along with oleic acid in 1 studies

Compound Research Comparison

Studies (sorafenib)	Trials (sorafenib)	Recent Studies (post-2010) (sorafenib)	Studies (oleic acid)	Trials (oleic acid)	Recent Studies (post-2010) (oleic acid)
6,520	730	5,251	8,768	248	3,051

Protein Interaction Comparison

Protein	Taxonomy	sorafenib (IC50)	oleic acid (IC50)
Tyrosine-protein phosphatase non-receptor type 1	Homo sapiens (human)		6.2

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, R; Kuang, S; Liu, G; Peng, Q; Sun, C; Wang, J	1

Other Studies

1 other study(ies) available for sorafenib and oleic acid

Article	Year
Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:9 Topics: Adenosine Triphosphate; Adenylate Kinase; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Activation; Fatty Acids, Monounsaturated; Humans; Lipidomics; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Proteins; Oleic Acid; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Sorafenib; Stearoyl-CoA Desaturase; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays	2019

Article

Year

Sorafenib kills liver cancer cells by disrupting SCD1-mediated synthesis of monounsaturated fatty acids

FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019, Volume: 33, Issue:9

Topics: Adenosine Triphosphate; Adenylate Kinase; Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Line, Tumor; Enzyme Activation; Fatty Acids, Monounsaturated; Humans; Lipidomics; Liver Neoplasms; Male; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Proteins; Oleic Acid; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Recombinant Proteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Sorafenib; Stearoyl-CoA Desaturase; Sterol Regulatory Element Binding Protein 1; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2019